KV Pharmaceutical names new CFO
This article was originally published in Scrip
Executive Summary
KV Pharmaceutical Company (US) has named Stephen Stamp chief financial officer and treasurer. He has more than 27 years' finance experience, having most recently served as chief operating officer and chief financial officer at Xanodyne Pharmaceuticals. Before that, Mr Stamp spent five years at Shire Pharmaceuticals as group finance director.